Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
MicroRNA Targets for Chemoprevention of Squamous Cell Carcinoma (R01 CA194062-01A1)
Outer and Inner Hair Cell Development
A Potent Small Molecule Sigma1 Modulator Degrades Androgen Receptor In Castration Resistant Prostate Cancer
Cell-Matrix Interactions in Limb Development
Glucose Tolerance/Lipid Metabolism/Users of Norgestrel
Recently added grants:
HIV/HCV-related health disparities in Baltimore: from community to lab bench
RCMI@Morgan: Center for Urban Health Disparities Research and Innovation
Optimized Stents for the Femoropopliteal Artery
The Cause of Systemic Inflammatory Response during Cardiopulmonary Bypass and Prevention by Nitric Oxide
Novel medical adjunctive therapy to catheter ablation for atrial fibrillation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM52207-10-0-1
Application #
7568639
Study Section
Project Start
2004-12-15
Project End
2009-12-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/ University of Alabama Birmingham
$244,166
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Hill, Donald /
$233,463
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/
NIH 2007
N01 CA
Assay Development and Initial Pharmacology Studies with SMA-491
/
NIH 2007
N01 CA
/
Comments
Be the first to comment on this grant